BIOLINGUS (CAYMAN) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • December 19th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations • New York
Poly Building Office Room B2133 Lease AgreementPoly Building • December 19th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations
DOMICILE AGREEMENTDomicile Agreement • July 13th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations
WHEREAS, the Lessor is represented by Mr Robert Landolt, who has the sufficient authority and faculties to execute this agreement.
Confidential BIOLINGUS EMPLOYMENT AGREEMENT between BioLingus (Hong Kong) Limited Unit 1904, 19/F, Podium Plaza, 5 Hanoi Road, Tsimshatsui, Kowloon, Hong Kong (hereinafter: “Employer”) and Ko Sai Ying born on July 22nd 1945, Hong Kong & Australian citizenEmployment Agreement • July 13th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations • Hong Kong
LICENSE AGREEMENTLicense Agreement • July 13th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations
BioLingus IP GmbH (“BioLingus I”), a company incorporated in Switzerland and having its registered office at Grossmatt 6 CH-6052 Hergiswil NW, Switzerland (hereinafter referred to as “Licensor”, which expression shall, unless it be repugnant to the context or meaning thereof, be deemed to mean and include its successors and permitted assigns) of the ONE PART;
INNOVATION PARK BASEL AREA SUBLEASE AGREEMENTSublease Agreement • March 29th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations
The lease commences on 01.02.2020. From this date the lessee owes the rent defined in Art 2. The lease ends on 31.12.2022 without notice. During the rental period, the rental agreement can be terminated in writing at the end of a month, subject to a notice period of six months.
